NZ333914A - Use of benzothiophene (raloxifene) derivatives in treatment of osteoporosis, lowering serum cholesterol levels and inhibiting estrogen dependent cancer
- Google Patents
Use of benzothiophene (raloxifene) derivatives in treatment of osteoporosis, lowering serum cholesterol levels and inhibiting estrogen dependent cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9604912.7Aexternal-prioritypatent/GB9604912D0/en
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Publication of NZ333914ApublicationCriticalpatent/NZ333914A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
This use of benzothiophenes of the formula I ; where R1 is H, OH, alkoxy, OC(O)alkyl, OC(O)Oalkyl, OC(O)phenyl, OC(O)Ophenyl or SO2alkyl, R2 is R1, Cl or F, R3 and R4 each are alkyl or combine to form a morpholine or a 5-8 membered nitrogen containing hetero ring and X is CH2, CHOH, O or CO; is for inhibiting osteoporosis, lowering serum cholesterol levels and inhibiting estrogen-dependent cancer.
NZ333914A1996-02-221999-01-26Use of benzothiophene (raloxifene) derivatives in treatment of osteoporosis, lowering serum cholesterol levels and inhibiting estrogen dependent cancer
NZ333914A
(en)
Use of benzothiophene (raloxifene) derivatives in treatment of osteoporosis, lowering serum cholesterol levels and inhibiting estrogen dependent cancer
Use of benzothiophene (raloxifene) derivatives in treatment of osteoporosis, lowering serum cholesterol levels and inhibiting estrogen dependent cancer